Skip to content

Conversion of haridradi oil to cream to study their effect in patients with melasma

A comparitive pharmaceutico analytical and clinical evaluation of Haridradi taila and conversion to cream in the management of vyanga w.s.r to melasma - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070086
Enrollment
40
Registered
2024-07-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L819- Disorder of pigmentation, unspecified

Interventions

None listed

Sponsors

Dr Swathi K S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with clinical signs of Vyanga as per Ayurvedic classics will be included. 2. Patients between age group of 16 to 60 years will be selected for the study. 3. Patients irrespective of sex, religion and occupation will be selected for the study.

Exclusion criteria

Exclusion criteria: 1. Female on oral contraceptive pills, pregnant women, lactating women. 2. Hyperpigmentation since birth. 3. Any other condition interfering the course of treatment.

Design outcomes

Primary

MeasureTime frame
1. Number of circular lesions 2. Color of skin lesion 3. Area of distribution of skin lesionTimepoint: 21 days

Secondary

MeasureTime frame
Not applicableTimepoint: Not applicable

Countries

India

Contacts

Public ContactDr Swathi K S

ALN Rao Memorial Ayurvedic Medical College

jagdeeshmayya@gmail.com9448525235

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026